MDxHealth SA MDXH-Product Pipeline Analysis, 2016 Update

MDxHealth SA MDXH-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME82376PD
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

MdxHealth SA (MdxHealth) is a healthcare company. It develops and commercializes advanced epigenetic assays and service testing for the early detection of cancer and personalized treatment decisions. It offers clinical molecular diagnostics solutions and pharmaco molecular diagnostics solutions. The company's products include ConfirmMDx, which detects absence or presence of prostate cancer; PredictMDx, which indicates patient response to therapy. MdxHealth tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also offers biomarker development services to many pharmaceutical companies. MdxHealth markets its products through sales forces, partnerships and distributors. The company has operations in Belgium and the US. MdxHealth is headquartered in Herstal, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company MDxHealth SA

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

MDxHealth SA Company Snapshot 6

MDxHealth SA Company Overview 6

MDxHealth SA Pipeline Products and Clinical Trials Overview 7

MDxHealth SA-Pipeline Analysis Overview 9

Business Description 9

Key Facts 9

MDxHealth SA-Major Products and Services 10

MDxHealth SA Pipeline Products by Development Stage 11

MDxHealth SA Pipeline Products Overview 13

AssureMDx-Bladder Cancer 13

AssureMDx-Bladder Cancer Product Overview 13

Bladder ConfirmMDx 14

Bladder ConfirmMDx Product Overview 14

Bladder RecurMdx 15

Bladder RecurMdx Product Overview 15

ClinicalMDx-Cervical Cancer 16

ClinicalMDx-Cervical Cancer Product Overview 16

ConfirmMDx-Lung Cancer 17

ConfirmMDx-Lung Cancer Product Overview 17

InformMDx-Colon Cancer 18

InformMDx-Colon Cancer Product Overview 18

InformMDx-Prostate Cancer 19

InformMDx-Prostate Cancer Product Overview 19

Molecular Diagnostic Test-Bladder Cancer 20

Molecular Diagnostic Test-Bladder Cancer Product Overview 20

Molecular Diagnostic Test-Kidney Cancer 21

Molecular Diagnostic Test-Kidney Cancer Product Overview 21

PharmacoDx-Breast Cancer 22

PharmacoDx-Breast Cancer Product Overview 22

PharmacoDx-Lung Cancer 23

PharmacoDx-Lung Cancer Product Overview 23

PharmacoDx-Ovarian Cancer 24

PharmacoDx-Ovarian Cancer Product Overview 24

PredictMDx-Colon Cancer 25

PredictMDx-Colon Cancer Product Overview 25

MDxHealth SA-Key Competitors 26

MDxHealth SA-Key Employees 27

MDxHealth SA-Key Employee Biographies 28

MDxHealth SA-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

MDxHealth SA, Recent Developments 30

May 09, 2016: MDxHealth's ConfirmMDx Stratifies Risk For Aggressive Prostate Cancer 30

May 06, 2016: MDxHealth Announces Positive Data Supporting Prognostic Value of ConfirmMDx for Prostate Cancer 30

May 06, 2016: MDxHealth Announces Positive Data Supporting Prognostic Value of SelectMDx for Prostate Cancer 31

May 03, 2016: MDxHealth Provides First Quarter 2016 Business Update 31

Apr 25, 2016: MDxHealth's SelectMDx Study Published in European Urology 33

Apr 25, 2016: MDxHealth's SelectMDx Study Published in European Urology 33

Mar 29, 2016: MDxHealth Partners with Andros Men's Clinic to Offer SelectMDx for Prostate Cancer 34

Mar 17, 2016: MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States 35

Mar 14, 2016: MDxHealth Presents SelectMDx Results from Multicenter Validation Study at the 2016 Annual EAU Congress 35

Mar 09, 2016: MDxHealth Appoints Global Commercial Team for SelectMDx 36

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

MDxHealth SA Pipeline Products by Equipment Type 8

MDxHealth SA Pipeline Products by Development Stage 11

List of Tables

MDxHealth SA Pipeline Products and Clinical Trials Overview 7

MDxHealth SA Pipeline Products by Equipment Type 7

MDxHealth SA Pipeline Products by Indication 8

MDxHealth SA, Key Facts 9

MDxHealth SA, Major Products and Services 10

MDxHealth SA Number of Pipeline Products by Development Stage 11

MDxHealth SA Pipeline Products Summary by Development Stage 12

AssureMDx-Bladder Cancer-Product Status 13

AssureMDx-Bladder Cancer-Product Description 13

Bladder ConfirmMDx-Product Status 14

Bladder ConfirmMDx-Product Description 14

Bladder RecurMdx-Product Status 15

Bladder RecurMdx-Product Description 15

ClinicalMDx-Cervical Cancer-Product Status 16

ClinicalMDx-Cervical Cancer-Product Description 16

ConfirmMDx-Lung Cancer-Product Status 17

ConfirmMDx-Lung Cancer-Product Description 17

InformMDx-Colon Cancer-Product Status 18

InformMDx-Colon Cancer-Product Description 18

InformMDx-Prostate Cancer-Product Status 19

InformMDx-Prostate Cancer-Product Description 19

Molecular Diagnostic Test-Bladder Cancer-Product Status 20

Molecular Diagnostic Test-Bladder Cancer-Product Description 20

Molecular Diagnostic Test-Kidney Cancer-Product Status 21

Molecular Diagnostic Test-Kidney Cancer-Product Description 21

PharmacoDx-Breast Cancer-Product Status 22

PharmacoDx-Breast Cancer-Product Description 22

PharmacoDx-Lung Cancer-Product Status 23

PharmacoDx-Lung Cancer-Product Description 23

PharmacoDx-Ovarian Cancer-Product Status 24

PharmacoDx-Ovarian Cancer-Product Description 24

PredictMDx-Colon Cancer-Product Status 25

PredictMDx-Colon Cancer-Product Description 25

MDxHealth SA, Key Employees 27

MDxHealth SA, Key Employee Biographies 28

MDxHealth SA, Other Locations 29

MDxHealth SA, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

OPKO Health, Inc.

Hologic Ltd.

Beckman Coulter, Inc.

Mitomics Inc.

Myriad Genetics, Inc.

Agendia BV

Epigenomics AG

Genomic Health, Inc.

MDxHealth SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48270
Site License
USD 1500 INR 96540
Corporate User License
USD 2250 INR 144810

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com